Recombinant Human PLA2G1B (C-6His)

Recombinant Human PLA2G1B (C-6

His)
收藏
  • ¥1080 - 11000
  • EnkiLife
  • PHH1333
  • 2025年10月21日
    avatar
  • 企业认证

    • 详细信息
    • 技术资料
    • 英文名

      PLA2G1B/Phospholipase A2/PLA2/PLA2A/PPLA2

    • 供应商

      武汉恩玑生命科技有限公司

    • 规格

      10ug/50ug/500ug

    规格:10ug产品价格:¥1080.0
    规格:50ug产品价格:¥3180.0
    规格:500ug产品价格:¥11000.0
    产品名称

    Recombinant Human PLA2G1B (C-6His)

    英文名称

    PLA2G1B/Phospholipase A2/PLA2/PLA2A/PPLA2  

    纯度

    Greater than 95% as determined by reducing SDS-PAGE

    内毒素

    <1 EU/µg as determined by LAL test.

    蛋白构建

    Recombinant Human Phospholipase A2 Group IB is produced by our Mammalian expression system and the target gene encoding Ala23-Ser148 is expressed with a 6His tag at the C-terminus.

    Accession

    P04054

    表达宿主

    Human Cells

    种属

    Human

    预测分子量

    15.2 KDa

    制剂

    Supplied as a 0.2 μm filtered solution of 20mM Tris-HCl, 150mM NaCl, 10% Glycerol, pH 8.0.

    运输方式

    The product is shipped on dry ice/polar packs.Upon receipt, store it immediately at the temperature listed below.

    稳定性&储存

    Store at ≤-70°C, stable for 6 months after receipt.Store at ≤-70°C, stable for 3 months under sterile conditions after opening. Please minimize freeze-thaw cycles.

    复溶

     

    分子别名
    PLA2G1B;Phospholipase A2;Group IB phospholipase A2;PLA2;PLA2A;PPLA2

     

    背景介绍
    Phospholipase A2(PLA2G1B) is a secreted protein which belongs to the phospholipase A2 family. It catalyzes the release of fatty acids from glycero-3-phosphocholines. It catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. This releases glycerophospholipids and arachidonic acid that serve as the precursors of signal molecules. Sequences of pancreatic PLA2G1B enzymes from a variety of mammals have been reported. One striking feature of these enzymes is their close homology to venom phospholipases of snakes. Mice lacking in PLA2G1B are resistant to obesity and diabetes induced by feeding a diabetogenic high-fat/high-carbohydrate diet. Oral supplementation of a diabetogenic diet with the PLA2G1B inhibitor methyl indoxam effectively suppresses diet-induced obesity and diabetes. PLA2G1B inhibition may be a potentially effective oral therapeutic option for treatment of obesity and diabetes.

     

    注意事项

    本司产品仅用于科研,不用于临床诊断和治疗

     

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥1080
    武汉恩玑生命科技有限公司
    2025年09月04日询价
    ¥1200
    苏州近岸蛋白质科技股份有限公司
    2025年08月30日询价
    询价
    南京赛戈巍生物科技有限公司
    2025年06月20日询价
    ¥840
    上海研卉生物科技有限公司
    2025年10月17日询价
    ¥2086
    武汉益普生物科技有限公司
    2025年07月11日询价
    Recombinant Human PLA2G1B (C-6His)
    ¥1080 - 11000